Real-time enrollment status for this solid tumors clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 12:08 PM UTC
| NCT Number | NCT05525247 |
| Recruiting Status | Recruiting |
| Condition | Solid Tumors |
| Phase | Clinical Trial |
| Target Enrollment | 420 participants |
| Active Locations | 3 sites in the US |
| Sponsor | Selecxine |
| Last Updated on CT.gov | September 21, 2023 (Sep 21, 2023) |
As of March 2, 2026: Clinical trial NCT05525247 is currently recruiting participants. This clinical trial study for solid tumors is actively seeking new participants at 3 locations across the United States. The study is sponsored by Selecxine. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05525247 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 3 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05525247 was last updated Sep 21, 2023 (September 21, 2023). HelloStudys verifies this status automatically.